Nouailles, Geraldine https://orcid.org/0000-0003-1973-3119
Wyler, Emanuel https://orcid.org/0000-0002-9884-1806
Pennitz, Peter https://orcid.org/0000-0002-8132-7237
Postmus, Dylan https://orcid.org/0000-0002-9551-0411
Vladimirova, Daria
Kazmierski, Julia https://orcid.org/0000-0002-7962-2165
Pott, Fabian https://orcid.org/0000-0003-3700-1691
Dietert, Kristina https://orcid.org/0000-0002-5667-6750
Muelleder, Michael
Farztdinov, Vadim
Obermayer, Benedikt https://orcid.org/0000-0002-9116-630X
Wienhold, Sandra-Maria https://orcid.org/0000-0001-5655-4350
Andreotti, Sandro
Hoefler, Thomas https://orcid.org/0000-0001-7486-5582
Sawitzki, Birgit
Drosten, Christian https://orcid.org/0000-0001-7923-0519
Sander, Leif E. https://orcid.org/0000-0002-0476-9947
Suttorp, Norbert
Ralser, Markus
Beule, Dieter https://orcid.org/0000-0002-3284-0632
Gruber, Achim D. https://orcid.org/0000-0002-4502-0393
Goffinet, Christine https://orcid.org/0000-0002-3959-004X
Landthaler, Markus https://orcid.org/0000-0002-1075-8734
Trimpert, Jakob https://orcid.org/0000-0003-1616-0810
Witzenrath, Martin
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01ZX1604B)
Article History
Received: 15 January 2021
Accepted: 13 July 2021
First Online: 11 August 2021
Competing interests
: G.N. received funding for research from Biotest AG. E.W., P.P., D.P., D.V., J.K., F.P., K.D., M.M., V.F., B.O., S.-M.W., S.A., T.H., B.S., C.D., L.E.S., N.S., M.R., D.B., A.D.G., C.G., M.L. and J.T declare no conflict of interest. M.W. received funding for research from Actelion, Bayer Health Care, Biotest AG, Boehringer Ingelheim, Noxxon, Pantherna, Quark Pharma, Vaxxilon, and for advisory from Actelion, Aptarion, Astra Zeneca, Bayer Health Care, Berlin Chemie, Biotest, Boehringer Ingelheim, Chiesi, Glaxo Smith Kline, Novartis, Noxxon, Pantherna, Teva and Vaxxilon. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.